首页 | 本学科首页   官方微博 | 高级检索  
     


Chk1 as a new therapeutic target in triple-negative breast cancer
Affiliation:1. Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA;2. Department of Internal Medicine, Division of Oncology–Hematology, VA Nebraska Western Iowa Health Care System, University of Nebraska Medical Center, Omaha, NE, USA;1. Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA;2. Department of Pharmacy, Hartford Hospital, Hartford, CT, USA;1. Division of Chemical Pathology, National Health Laboratory Service, Tygerberg Hospital, University of Stellenbosch Medical School, South Africa;2. Department of Chemical Pathology, National Health Laboratory Service, University of Witwatersrand Medical School, Parktown, South Africa;3. Department of Internal Medicine, University of Witwatersrand Medical School, Parktown, South Africa;4. Department of Surgery, University of Witwatersrand Medical School, Parktown, South Africa
Abstract:
Keywords:Cell growth  Chk1  Mitotic catastrophe  Triple-negative breast cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号